South Dakota 2026 Regular Session

South Dakota Senate Bill SB14

Introduced
1/13/26  
Refer
1/13/26  
Report Pass
1/26/26  
Engrossed
1/27/26  
Refer
1/28/26  
Report Pass
2/24/26  
Enrolled
2/25/26  

Caption

Modify provisions related to the practice of pharmacy.

Impact

The modifications outlined in SB14 are expected to enhance the operational flexibility of pharmacies. By permitting the use of remote drop sites, the bill seeks to improve patient satisfaction and convenience, particularly for those who may find it difficult to visit pharmacies in person. Moreover, the strict requirements for pharmacist supervision in these operations aim to maintain the integrity of pharmaceutical practices and safeguard patient health. The amendments could also streamline the licensing process for pharmacies, adapting to modern needs and improving efficiency in the delivery of healthcare.

Summary

Senate Bill 14 (SB14) aims to modify various provisions related to the practice of pharmacy within the state. This bill involves amendments to existing regulations surrounding pharmacy operations, with a particular focus on how drugs are delivered and the supervision required for dispensing medications. Notably, the bill introduces the concept of remote drop sites for the delivery of prescription drugs, promoting greater access to medication delivery services while ensuring that these operations remain under the oversight of licensed pharmacists.

Sentiment

The sentiment surrounding SB14 appears largely positive among proponents, who argue that it will increase access to pharmaceutical services. Supporters include legislators interested in enhancing healthcare delivery in the state, emphasizing the need for a more adaptable pharmacy framework that meets contemporary patient needs. However, there are also concerns voiced by some stakeholders regarding the risks involved in remote drug delivery, particularly around potential misuse and ensuring continued pharmacist oversight to prevent medication errors.

Contention

A notable point of contention regarding SB14 is the balance between expanding access to pharmacy services and maintaining robust oversight to protect patient safety. Critics express apprehension over the possible implications of remote drop sites, fearing that the integrity of the pharmacist's role could diminish. Concerns are also raised about ensuring that delivery processes do not compromise the standards of care expected in pharmacological practices. Overall, while the bill is well-intentioned, it has sparked discussions about the future landscape of pharmacy practice and necessary safeguards.

Companion Bills

No companion bills found.

Previously Filed As

SD HB1016

Revise provisions related to pharmacy and to increase fees.

SD SB154

Prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.

SD HB1071

Modify practice criteria for physician assistants.

SD SB102

Revise provisions related to the practice of physician assistants.

SD HB1101

Repeal provisions related to medical marijuana.

SD HB1056

Prohibit the preparation, sale, and distribution of certain kratom products and to provide a penalty therefor.

SD HB1216

Modify and repeal provisions related to the Legislative Research Council.

SD HB1055

Modify medical cannabis certification requirements.

SD SB59

Revise provisions relating to the delivery, possession with intent to deliver, and possession of unauthorized articles in a state correctional facility, and to provide a penalty therefor.

SD SB48

Modify provisions pertaining to the registration of voters.

Similar Bills

No similar bills found.